http://www.pharmachemm.com
Home > Industry Information > FDA OKs Teligent's lidocaine and prilocaine cream; shares up 6% premarket
Industry Information

FDA OKs Teligent's lidocaine and prilocaine cream; shares up 6% premarket

2018-08-16

Micro cap Teligent (NASDAQ:TLGT) is up 6% premarket on light volume in response to the FDA approval for its Lidocaine and Prilocaine Cream USP, 2.5%/2.5%, its seventh approval this year.

Per IQVIA, the U.S. market is ~$44M.
Previous: Voriconazole Next: 43 Drugs Going Generic in the Next 5 Years

Related Products

Communicate with Supplier?Supplier
Mr. Vid Mr. Mr. Vid
What can I do for you?
Contact Supplier